Planet 13 Holdings (PLNH) EPS (Basic) Growth (1y) (2022 - 2026)
Planet 13 Holdings (PLNH) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | 58.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.33% |
| Mar 31, 2026 | -292.26% |
| Dec 31, 2025 | 123.80% |
| Sep 30, 2025 | -492.74% |
| Jun 30, 2025 | -46.43% |
| Mar 31, 2025 | 75.52% |
| Dec 31, 2024 | -40.87% |
| Sep 30, 2024 | 89.06% |
| Jun 30, 2024 | -34.14% |
| Mar 31, 2024 | 32.96% |
| Dec 31, 2023 | 66.95% |
| Sep 30, 2023 | -625.20% |
| Jun 30, 2023 | 35.21% |
| Mar 31, 2023 | -94.15% |
| Dec 31, 2022 | -204.43% |
| Sep 30, 2022 | -239.06% |
| Jun 30, 2022 | -1,912.07% |
| Mar 31, 2022 | 37.33% |